International Journal of Advanced and Integrated Medical Sciences

Register      Login

VOLUME 3 , ISSUE 1 ( March, 2018 ) > List of Articles

CASE REPORT

Plexiform Neurofibroma as an Uncommon Cause of Periorbital Swelling

Abhinav Srivastava, Yusuf Rizvi, Vaibhav Yadav

Keywords : Plexiform neurofibroma, Proptosis, Surgical excision

Citation Information : Srivastava A, Rizvi Y, Yadav V. Plexiform Neurofibroma as an Uncommon Cause of Periorbital Swelling. Int J Adv Integ Med Sci 2018; 3 (1):41-43.

DOI: 10.5005/jp-journals-10050-10120

License: CC BY-SA 4.0

Published Online: 01-06-2019

Copyright Statement:  Copyright © 2018; The Author(s).


Abstract

Introduction: Plexiform neurofibromas are benign tumors originating from subcutaneous or visceral peripheral nerves, which are usually associated with neurofibromatosis type I. Orbital neurofibromas are relatively rare and usually present with high infiltration into the periocular structures making the management extremely difficult. Purpose: To r eport a c ase o f p lexiform n eurofibroma w ith neurofibromatosis type I in a young boy managed satisfactorily with surgical excision. Materials and methods: A 14-year-old boy presenting with a soft, painless, nontender, gradually enlarging swelling of the left upper eyelid and adjacent temporal region and of 6 years duration was managed with complete surgical excision. Histopathological examination of excised mass confirmed the diagnosis of neurofibroma. Results: Satisfactory functional and cosmetic result was achieved following surgical excision of the subcutaneous fibromatous mass. A 1-year follow-up did not reveal any functional deficit or recurrence. Conclusion: Plexiform neurofibroma may present as an uncommon cause of periorbital swelling even in the absence of typical features of neurofibromatosis type I and can be surgically managed to achieve acceptable cosmetic and functional results.


PDF Share
  1. Savar A, Cestari DM. Neurofibromatosis type I: genetics and clinical manifestations. Semin Ophthalmol 2008 Jan-Feb; 23(1):45-51.
  2. Erb MH, Uzcategui N, See RF, Burnstine MA. Orbitotemporal neurofibromatosis: classification and treatment. Orbit 2007 Dec;26(4):223-228.
  3. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 1986 May;57(10): 2006-2021.
  4. Sippel KC. Ocular findings in neurofibromatosis type 1. Int Ophthalmol Clin 2001;41(1):25-40.
  5. Avery RA, Dombi E, Hutcheson KA, Acosta MT, Baldwin AM, Madigan WP et al. Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas. Am J Ophthalmol 2013 Jun;155(6):1089.e1-1094.e1.
  6. Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a paediatric neurooncology program. Neuro Oncol 2007 Oct;9(4): 430-437.
  7. Hwang JM, Cheon JE, Wang KC. Visual prognosis of optic glioma. Childs Nerv Syst 2008 Jun;24(6):693-698.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.